Postponement of menses, suppression of urinary gonadotrophins, 17-KGS and 17-KS in normal women treated with a megestrol acetate/mestranol combination (delpregnin) from day 20 of the cycle.
D015068:17-Ketosteroids / Q000652:urine*; D000328:Adult; D000738:Androsterone / Q000652:urine; D003276:Contraceptives, Oral / Q000494:pharmacology*; D003687:Dehydroepiandrosterone / Q000652:urine; D004357:Drug Synergism; D005043:Etiocholanolone / Q000652:urine; D005260:Female; D006062:Gonadotropins / Q000652:urine*; D006801:Humans; D008535:Megestrol / Q000494:pharmacology; D008598:Menstruation / Q000187:drug effects*; D008656:Mestranol / Q000494:pharmacology*; D011372:Progestins / Q000494:pharmacology*
D015068:17-Ketosteroids; D003276:Contraceptives, Oral; D006062:Gonadotropins; D011372:Progestins; D003687:Dehydroepiandrosterone; D005043:Etiocholanolone; D008656:Mestranol; D000738:Androsterone; D008535:Megestrol